Inflammatory markers in patients after hematopoietic stem cell transplantation

scientific article published on 07 April 2013

Inflammatory markers in patients after hematopoietic stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030536618
P356DOI10.1007/S00005-013-0228-Z
P698PubMed publication ID23563864
P5875ResearchGate publication ID236128583

P50authorEmilian SnarskiQ61312771
P2093author name stringCamilla Sjøqvist
P2860cites workProcalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adultsQ33306998
Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantationQ33781213
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patientsQ35755733
Mucosal damage: a major risk factor for severe complications after cytotoxic therapyQ35794838
Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.Q37210062
Challenges and advances in infection control of hematopoietic stem cell transplant recipientsQ37837928
Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsisQ39667239
Febrile mucositis in haematopoietic SCT recipientsQ40410560
Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantationQ40541991
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteriaQ40563612
An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell doseQ40624714
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single centerQ43198285
The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantationQ44139119
Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortalityQ44881735
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimensQ46450537
C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancerQ48016794
Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.Q51005334
P433issue4
P921main subjectstem cell transplantationQ65592366
P304page(s)301-307
P577publication date2013-04-07
P1433published inArchivum Immunologiae et Therapiae ExperimentalisQ15760838
P1476titleInflammatory markers in patients after hematopoietic stem cell transplantation
P478volume61

Reverse relations

cites work (P2860)
Q41445916Diagnostic potential of inflammatory markers in septic arthritis and periprosthetic joint infections: a clinical study with 719 patients
Q37208589Impact of pre-transplant pulmonary infection developed in horizontal laminar flow unit on the outcome of subsequent allogeneic hematopoietic stem cell transplantation
Q38434710MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Q49228781Protein dysregulation in graft versus host disease
Q40474709The clinical value of biomarkers in respiratory complications in hematopoietic SCT.

Search more.